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Abstract
Background: Spontaneous bacterial peritonitis (SBP) is a common and life-threatening infection in patients with advanced
cirrhosis. The prognostic value of a novel marker, the delta neutrophil index (DNI), was investigated relative to mortality in
patients with SBP.
Materials & Methods: Seventy-five patients with SBP were studied from April 2010 to May 2012. DNI at initial diagnosis of
SBP was determined and compared with 30-day mortality rates.
Results: Of the patients, 87.7% were men, and the median age of all patients was 59.0 yrs. The area under the receiver-
operating characteristic (ROC) curve of DNI for 30-day mortality was 0.701 (95% confidence interval [CI], 0.553–0.849;
p= 0.009), which was higher than that of C-reactive protein (0.640, 95% CI, 0.494–0.786; p= 0.076) or the model for end-
stage liver disease score (0.592, 95% CI, 0.436–0.748; p= 0.235). From the ROC curve, with the sum of sensitivity and
specificity, the cutoff value of DNI was determined to be 5.7%. In the high-DNI group (DNI $5.7%), septic shock and 30-day
mortality were more prevalent compared with the low-DNI group (84.2% vs. 48.2%, p= 0.007; 57.9% vs. 14.3%, p,0.001,
respectively). Patients with an elevated DNI had a higher risk of 30-day mortality compared with those with a low DNI (4.225,
95% CI, 1.631–10.949; p= 0.003).
Conclusion: A higher DNI at the time of SBP diagnosis is an independent predictor of 30-day mortality in patients with SBP.
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Introduction
In patients with advanced cirrhosis, spontaneous bacterial
peritonitis (SBP) is a common and life-threatening infection that
requires prompt recognition and treatment. It is characterized by
the presence of .250 polymorphonuclear cells (PMN)/mm3 in
ascites in the absence of an intra-abdominal source of infection
[1,2]. Despite advances in the knowledge of bacterial cirrhosis
pathogenesis and developments of appropriate treatment strate-
gies, the mortality rate of SBP remains at 20% [3–5].
Studies have attempted to establish reliable criteria that are
useful for the diagnosis and management of bacterial infection. But
for patients with cirrhosis, the prognostic capabilities of conven-
tional parameters such as systemic inflammatory response
syndrome (SIRS) and C-reactive protein (CRP) are relatively
limited [6]. It is difficult to assess SIRS in cirrhotic patients
because of hypersplenism-induced neutropenia, increased heart
rate associated with hyperkinetic circulatory syndrome, and/or
hyperventilation caused by hepatic encephalopathy [7]. Further-
more, since CRP is produced predominantly by hepatocytes [8],
patients with liver failure could already present with attenuated
production regardless of infection.
During stress or infection, immature neutrophils enter the
circulation. Termed ‘‘left-shift,’’ this manifestation is defined as an
elevated ratio of immature granulocytes to total granulocytes [9].
It can be a useful marker of infection in clinical practice, but a
more reliable and reproducible determining factor may be
required. Recent technological advances have led to modern
automated cell analyzers that can provide information on
leukocyte differentials based on the nuclear lobularity of white
blood cells (WBCs) and cytochemical myeloperoxidase (MPO)
reaction [10,11].
The delta neutrophil index (DNI), the difference between the
leukocyte differentials computed in the MPO channel and those
calculated in the nuclear lobularity channel [12], is significantly
associated with disseminated intravascular coagulation scores, a
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positive blood culture rate, and mortality in patients with
suspected sepsis [12]. Some studies have reported that, compared
with WBC or CRP levels, DNI is a more useful marker for
predicting mortality in patients with sepsis [13–15]. For
patients with advanced cirrhosis who have been diagnosed with
SBP, little is known about the clinical usefulness of DNI in
evaluating infection severity of about how it relates to overall
mortality. Therefore, this investigation focused on DNI values in
patients with advanced cirrhosis who were treated for SBP and
evaluated the clinical utility of DNI as a prognostic indicator of
mortality.
Patients and Methods
Patients
143 consecutive patients diagnosed with SBP and admitted to
Severance Hospital from April 2010 to May 2012 were retrospec-
tively studied. The following patients were subsequently excluded
from the study: 40 patients with hepatocellular carcinoma, six
patients who had other cancers, and 22 patients whose ascites was
caused by either pancreatitis or tuberculosis or whose culture
results were suggestive of polymicrobial secondary bacterial
peritonitis. After these exclusions, 75 cirrhotic patients with SBP
were enrolled in the study. Liver cirrhosis was diagnosed based on
histological, clinical, biochemical, or morphological results. Study
protocol followed the ethical guidelines of the 1975 Declaration of
Helsinki. Written informed consent was obtained from each
participant or a responsible family member after the procedure
and possible complications were fully explained.
Diagnosis and Treatment of SBP
SBP diagnosis required ascitic fluid to have a polymorphonu-
clear (PMN) leukocyte count .250 cells/mm3 [1,2]. Paracentesis
was performed, and the extracted peritoneal fluid was sent for
PMN count and culture study. Patients were initially treated with
intravenous cefotaxime, but broad-spectrum antibiotics such as
piperacillin–tazobactam or carbapenem were used in patients with
septic shock based on hospital guidelines for SBP treatment [16].
Blood sampling for DNI value and culture study was performed
prior to administration of antibiotics. Multi-drug resistant (MDR)
bacteria were defined as organisms resistant to one or more kind of
antibiotics, which included methicillin-resistant Staphylococcus aureus
and extended-spectrum b-lactamase (ESBL)-producing Escherichia
coli [17]. After the bacterium was isolated in the culture study,
we decided to change or continue antibiotics according to
its sensitivity. For example, if ESBL-producing E.coli was isolated
in ascitic fluid, we changed the antibiotics to carbapenem. In
addition, glycopeptides such as vancomycin or teicoplanin
were added if methicillin-resistant gram-positive bacteria were
isolated.
Definition of Other Clinical Conditions
Community-acquired SBP was defined as diagnosis at #48 h of
hospitalization, whereas nosocomial SBP was categorized as
diagnosis .48 h from admission [18]. Septic shock was defined
as sepsis-induced hypotension with a systolic arterial pressure
,90 mmHg or mean arterial pressure ,60–65 mmHg that
persisted despite adequate fluid resuscitation. SIRS was defined
as the coexistence of two or more of the following conditions
resulting from infection: (1) temperature .38uC or ,36uC; (2)
heart rate.90 beats/min; (3) respiratory rate.20 breaths/min or
PaCO2,32 mmHg; and (4) WBC count .12000 cells/mm
3 or
,4000 cells/mm3 [19]. Acute renal failure (ARF) was defined
as a serum creatinine level .1.5 mg/dL in patients without
pre-existing renal dysfunction or increase of more than 50% in
patients with pre-existing renal dysfunction [16].
Assessment of DNI
Blood samples were analyzed at the time of SBP diagnosis, and
an automatic cell analyzer (ADVIA 2120 Hematology System,
Siemens Healthcare Diagnostics, Forchheim, Germany) was used
to calculate DNI [12]. This hematologic analyzer is flow
cytometry-based and analyzes WBC by both a MPO channel
and a lobularity/nuclear density channel.
After red blood cell lysis, the tungsten–halogen-based optical
system of the MPO channel measured cell size and stain intensity
in order to count and differentiate granulocytes, lymphocytes, and
monocytes based on their size and MPO content. Next, the laser
diode-based optical system of the lobularity/nuclear density
channel counted and classified the cells according to size,
lobularity, and nuclear density.
The resulting data were inserted in the following formula to
determine DNI:
DNI= (neutrophil subfraction and eosinophil subfraction mea-
sured in the MPO channel) 2 (PMN subfraction measured in the
nuclear lobularity channel).
Statistical Analysis
The major goal of this study was to predict 30-day mortality
rates based on DNI. Continuous variables were compared using
the Mann–Whitney U-tests. Chi-squared or Fisher’s exact tests
were used for categorical variables. To assess the diagnostic
performance of DNI and other parameters, receiver operating
characteristic (ROC) curves were constructed, and the areas under
the ROC curves (AUROC) were calculated. Next, the sensitivity,
specificity, positive predictive value (PPV), and negative predictive
value (NPV) were calculated using the ROC curves. The optimal
cutoff value of DNI to predict 30-day mortality was determined
using the Youden index method, which defines the cutoff in terms
of the maximal sum of sensitivity and specificity. Prognostic factors
for mortality were evaluated using univariate analysis and then
univariate predictors (p,0.05) were entered into multivariate Cox
proportional hazard analyses and adjusted hazard ratios with 95%
confidence intervals (CIs) were also calculated. A probability (p)
level of 0.05 was chosen for statistical significance, and statistically
significant variables were included in multivariate analysis.
Furthermore, Kaplan Meier analyses evaluated 30-day mortality
in the high- and low-DNI groups. Statistical analyses were
performed using SPSS (version 18.0, SPSS Inc., Chicago, IL,
USA).
Results
Population Baseline Characteristics
Baseline characteristics are presented in Table 1. A total of 75
patients of the original 143 selected were deemed eligible for this
study. The median age of the patients studied was 59.0 yr, and
87.7% were male. Eleven patients (14.7%) had previous SBP
history. The most common etiology of cirrhosis was chronic
hepatitis B virus infection (n=43, 57.3%). The median value of
DNI at the time of SBP diagnosis was 3.2%, and values from 0%
to 56.1%. Most patients were scored as Child-Pugh stage C
(n=60, 80%), and the median model for end-stage liver disease
(MELD) score was 19.0. The proportion of patients with positive
ascites culture, bacteremia, SIRS, and septic shock was 53.3%
(n=40), 36.0% (n=27), 82.7% (n=62), and 57.3% (n=43),
respectively. Thirty-day mortality occurred in 25.3% (n=19) of
patients.
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Microbiological findings of the ascitic fluid are summarized in
Table 2. The most common organism found was E. coli (n=13,
32.5%), followed by Klebsiella pneumoniae (n=7, 17.5%). Of 40
patients with positive ascites culture, the number of patients with
MDR bacteria was 11 (27.5%).
Usefulness and Accuracy of DNI as a Prognostic Factor of
SBP
To evaluate the ability of DNI to predict 30-day mortality, a
ROC curve was constructed (Fig. 1). The area under the ROC
curve of DNI for 30-day mortality was 0.701 (95% CI, 0.553–
0.849; p=0.009). This was higher than that for CRP (0.640, 95%
CI, 0.494–0.786; p=0.076) or the MELD score (0.592, 95% CI,
0.436–0.748; p=0.235). The optimal cutoff value of DNI,
obtained from the Youden index, was 5.7%, with sensitivity,
specificity, PPV, and NPV values of 57.9%, 85.7%, 57.9%, and
85.7%, respectively.
Comparisons of Variables Divided by Optimal Cutoff
Value
Clinical and laboratory variables in the high- ($5.7%) and low-
DNI (,5.7%) groups are compared in Table 3. In the high-DNI
group, septic shock and 30-day mortality occurred at greater
frequency than in the low-DNI group (84.2% vs. 48.2%,
p=0.007). The CRP, MELD, bacteremia, and SIRS levels were
all elevated in the high-DNI group, but the differences were not
statistically significant. The 30-day mortality rate was significantly
higher in patients with a DNI .5.7% at the onset of SBP (57.9%
vs. 14.3%, p,0.001) (Fig. 2).
Table 1. Baseline characteristics of patients with SBP.
Variables Total (n=75)
Male gender (%) 65 (87.7%)
Age, years 59.0 (38.0–82.0)
History of previous SBP (%) 11 (14.7%)
Etiology of liver cirrhosis
HBV (%)/HCV (%)/Alcohol/Others 43 (57.3%)/10 (13.3%)/14 (18.6%)/8 (10.7%)
Community acquired SBP/Nosocomial SBP 54 (72.0%)/21 (28.0%)
ARF 20 (26.7%)
WBC count, per mm3 7,840 (1230–28670)
DNI, % 3.2 (0.0–56.1)
CRP, mg/L 61.9 (4.5–205.5)
Albumin, g/dL 2.4 (1.5–3.3)
Total bilirubin, mg/dL 3.6 (0.5–34.0)
Creatinine, mg/dL 1.4 (0.5–6.7)
Prothrombin time, INR 1.4 (1.1–3.1)
Na (mEq/L) 132.0 (118.0–146.0)
Child Pugh stage (B (%)/C (%)) 15 (20.0%)/60 (80.0%)
Child Pugh score 11.0 (8.0–14.0)
MELD score 19.0 (8.0–35.0)
Norfloxacin prophylaxis 5 (6.6%)
Positive ascitic fluid culture (%) 40 (53.3%)
MDR bacteria in ascitic fluid culture (%) 11 (14.7%)
Bacteremia (%) 27 (36.0%)
SIRS (%) 62 (82.7%)
Septic shock (%) 43 (57.3%)
30-day mortality 19 (25.3%)
Data are reported as median (range) or number (%).
SBP, spontaneous bacterial peritonitis; HBV, Hepatitis B virus; HCV, Hepatitis C virus; ARF, acute renal failure; WBC, white blood cell count; DNI, delta neutrophil index;
CRP, C-reactive protein; MELD, model for end stage liver disease; MDR, multi-drug resistant; SIRS, systemic inflammatory response syndrome.
doi:10.1371/journal.pone.0086884.t001
Table 2. Organisms isolated in ascites.
Organisms Total (n=40), %
E. coli 13 (32.5%)
Klebsiella pneumoniae 7 (17.5%)
Enterobacter cloacae 4 (10.0%)
Enterococcus facium 4 (10.0%)
Aeromonas hydrophila 3 (7.5%)
Streptococcus mitis 2 (5.0%)
Staphylococcus aureus 2 (5.0%)
Citrobacter freundii 2 (5.0%)
Listeria monocytogenes 2 (5.0%)
Sphingomonas paucimobilis 1 (2.5%)
doi:10.1371/journal.pone.0086884.t002
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Univariate Cox proportional hazard analysis demonstrated that
a DNI greater than 5.7% (univariate hazard ratio, 5.496 [2.198–
13.746]; p,0.001) and the presence of septic shock (univariate
hazard ratio, 4.544 [1.323–15.606]; p=0.016) were unfavorable
risk factors with respect to 30-day mortality in patients with SBP
(Table 4). In the multivariate Cox proportional hazard analysis, a
DNI greater than 5.7% was the only independent risk factor for
30-day mortality (adjusted hazard ratio, 4.225 [1.631–10.949];
p=0.003).
Discussion
The present study demonstrates that DNI can be a useful
prognostic factor for 30-day mortality in patients with SBP. There
is no ‘‘gold standard’’ to detect sepsis early, and blood culture
results are usually reported after at least 48 h. On the other hand,
because levels of immature granulocytes, such as promyelocytes,
metamyelocytes, and myelocytes are known to increase in
infectious conditions [9,20], it was investigated as a predictor of
sepsis in several studies [21,22]. In previous studies, the proportion
of immature granulocytes correlated better with positive blood
culture results and infection compared to the WBC count [21].
Furthermore, in another report, immature granulocytes was
suggested as a predictor of neonatal sepsis [22]. However, it is
difficult to measure immature granulocytes accurately, and their
diagnostic value remains controversial. To overcome these
limitations, DNI, which is the difference between the leukocyte
differentials assayed in the MPO channel and those measured in
the nuclear lobularity channel, was initially designed as a reliable
and reproducible method to reflect immature granulocytes in
circulating blood [12]. Because complete blood count is routinely
evaluated in patients suspected of SBP, DNI can be easily
calculated [15]. Although some studies on SBP have evaluated
prognostic factors such as renal insufficiency, type of organism,
bacteremia, and MELD score [23–31], no standard marker has
been determined to predict SBP mortality. CRP [32] and SIRS
[33] are common diagnostic parameters suggested for use as
prognostic markers for SBP, but their values diminish when
considering cirrhotic patients [6]. Although DNI has been
suggested to predict mortality in other infectious conditions [12–
15,34], no reports have estimated the prognostic value of DNI in
cirrhotic patients with SBP.
Compiled data showed that the area under a ROC curve of
DNI for 30-day mortality was higher than that for CRP or MELD
score. Furthermore, the optimal cutoff value of DNI was identified
as 5.7%. Univariate analyses found that a DNI .5.7%, combined
with the presence of septic shock, was a significant predictor of 30-
day mortality in patients with SBP. Subsequent multivariate
analyses revealed that a DNI .5.7% was the only risk factor
necessary to predict 30-day mortality. Thus, patients with SBP
who show DNI values greater than 5.0% should be managed very
carefully.
Third-generation cephalosporins have been recommended as
the first line of antibiotic treatment for SBP. However, extended-
spectrum empirical antibiotics such as carbapenems and piper-
acillin/tazobactam may be considered in the high-DNI group, as
recent guidelines have recommended them for use in patients with
nosocomial SBP [16]. Although septic shock occurred more
frequently in the high-DNI group, as is consistent with other
studies [12,13,15,21,34], SIRS did not differ between the two
groups. This is presumably because SIRS does not reflect well the
infectious condition in cirrhotic patients due to factors such as
baseline neutropenia and beta blocker use [7]. Under this
hypothesis, one can raise the question whether there exists any
influence of neutropenia on the DNI value and its prognostic role.
In a similar study, Pyo et al. [35] investigated the role of DNI in
the discrimination between disease flare-up and infection in
patients with systemic lupus erythematosus patients in whom
leucopenia are observed in some patients and leukocytosis are also
frequently observed in other patients because of glucocorticoid
usage [36,37], indicating that DNI reflects the proportion of
immature granulocytes regardless of WBC count and can better
Figure 1. Receiver operating characteristic (ROC) curve using
DNI at the onset of SBP for 30-day mortality. The area under the
curve was 0.701 (95% CI, 0.553–0.849, p=0.009) for DNI, 0.640 (95% CI,
0.494–0.786, p= 0.076) for CRP, and 0.592 (95% CI, 0.436–0.748,
p= 0.235) for the MELD score.
doi:10.1371/journal.pone.0086884.g001
Figure 2. Kaplan–Meir plots for cumulative 30-day mortality in
patients with SBP using the cutoff value of DNI.
doi:10.1371/journal.pone.0086884.g002
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reflect infection than WBC count which can be affected by other
conditions without infection. Likewise, leucopenia is common also
in cirrhotic patients. Therefore, DNI may be a useful indicator
especially in cirrhotic patients with leucopenia. To confirm this
novel suggestion, further prospective study should be performed.
Recent reports have suggested that the MELD score could
predict mortality in patients with SBP [29–31]. However, in this
study, the MELD score was unable to predict 30-day mortality in
either univariate or multivariate Cox proportional hazard
analyses. This may be for several reasons. First, 80% of the
patients enrolled in this study were categorized as Child-Pugh class
C, so there may be no significant difference in underlying liver
function among patients with advanced cirrhosis. Second, because
MELD scores are commonly used as a 3-month mortality
indicator in patients awaiting liver transplantation [38], it may
not be possible to determine accurate associations between MELD
scores and infection-related, short-term mortality.
ARF has been known to be a risk factor for acute-on-chronic
liver failure in recent studies [39], but in our study, it had no effect
on 30-day survival. We believe that this phenomenon is a type 2
error caused by the small sample size (i.e., only 20 patients with
ARF). Although there is no statistical significance in the incidence
of ARF between the two groups, the high DNI group, which was
the independent predictor of 30-day mortality in our study, still
showed a trend toward a higher incidence of ARF compared with
the low DNI group (42.1% vs. 21.4%). Therefore, we believe that
ARF may affect 30-day mortality of SBP in a larger sample size.
The connections among SIRS, multi-organ failure, and
mortality have yet to be determined. Some studies have suggested
that when inflammatory stress is superimposed on baseline
cirrhosis, severe hemodynamic derangements may occur second-
ary to the accentuation of portal hypertension and reduction in
hepatic blood flow [40]. This results in an increased concentration
of asymmetric dimethylarginine, an endogenous nitric oxide
synthase inhibitor [41]. Mediators of SIRS such as interleukin-6,
interleukin-1ß, tumor necrosis factor-a, and nitric oxide may
modulate hepatic encephalopathy in cirrhotic patients [42]. More
recently, cirrhotic patients with SIRS were reported to exhibit
marked changes in the functional capacity of albumin due to the
accumulation of oxidatively modified albumin [43].
There are several limitations to this study. First, it was a
retrospective study based on a small population of patients who
were all treated at a single location. Second, prognosis and
mortality did not take into account variations that may have
existed due to the different antibiotics being administered for
treatment. Moreover, because only short-term mortality was
Table 3. Comparison of variables according to DNI cutoff value.
Variables
DNI ,5.7%
(n=56)
DNI $5.7%
(n=19) p-value
Male gender (%) 50 (89.3%) 15 (78.9%) 0.262
Age, years 60.0 (38.0–82.0) 58.0 (40.0–74.0) 0.884
History of previous SBP (%) 7 (12.5%) 4 (21.1%) 0.455
Etiology of liver cirrhosis
HBV (%)/HCV (%)/Alcohol/Others (%) 33 (58.9%)/5 (8.9%)/10
(17.9%)/8 (14.3%)
10 (52.6%)/5 (26.3%)/4
(21.1%)/0 (0.0%)
Community acquired SBP/Nosocomial SBP 37 (66.1%)/19 (33.9%) 15 (78.9%)/4 (21.1%) 0.293
ARF 12 (21.4%) 8 (42.1%) 0.078
WBC count, per mm3 7450 (1490.0–28670.0) 9390 (1230.0–20000.0) 0.893
DNI, % 2.3 (0.0–5.5) 16.0 (5.9–56.1) ,0.001
CRP, mg/L 58.6 (4.5–205.5) 64.0 (5.7–195.7) 0.345
Albumin, g/dL 2.4 (1.5–3.3) 2.2 (1.8–3.0) 0.082
Total bilirubin, mg/dL 3.6 (0.5–34.0) 4.2 (1.0–19.6) 0.626
Creatinine, mg/dL 1.3 (0.5–6.7) 1.7 (0.6–4.2) 0.145
Prothrombin time, INR 1.4 (1.1–3.0) 1.5 (1.0–3.1) 0.214
Na (mEq/L) 132.0 (118.0–146.0) 129.0 (120.0–140.0) 0.166
Child Pugh stage (B (%)/C (%)) 12(21.4%)/44 (78.6%) 3 (15.8%)/16 (84.2%) 0.747
Child Pugh score 11.0 (8.0–13.0) 11.0 (9.0–14.0) 0.110
MELD score 19.0 (8.0–34.0) 22.0 (13.0–35.0) 0.059
Norfloxacin prophylaxis 4 (7.1%) 1 (5.3%) 1.000
Positive ascitic fluid culture (%) 29 (51.8%) 11 (57.9%) 0.645
MDR bacteria in ascitic fluid culture (%) 8 (14.3%) 3 (15.8%) 1.000
Bacteremia (%) 18 (32.1%) 9 (47.4%) 0.232
SIRS (%) 44 (78.6%) 18 (94.7%) 0.164
Septic shock (%) 27 (48.2%) 16 (84.2%) 0.007
30-day mortality 8 (14.3%) 11 (57.9%) ,0.001
Data are presented as median (range) or number (%).
SBP, spontaneous bacterial peritonitis; HBV, hepatitis B virus; HCV, hepatitis C virus; ARF, acute renal failure; WBC, white blood cell count; DNI, delta neutrophil index;
CRP, C-reactive protein; MELD, model for end stage liver disease; MDR, multi-drug resistant; SIRS, systemic inflammatory response syndrome.
doi:10.1371/journal.pone.0086884.t003
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evaluated, it is unknown whether DNI can predict long-term
mortality in SBP as well.
In conclusion, DNI at diagnosis of SBP is a useful prognostic
factor for the determination of 30-day mortality. Patients with high
DNI level should be cautiously monitored, and treatment
strategies should be appropriately adapted for their future needs.
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